Matches in DBpedia 2014 for { <http://dbpedia.org/resource/GenVec> ?p ?o. }
Showing items 1 to 63 of
63
with 100 items per page.
- GenVec abstract "GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. GenVec currently has a collaboration with Novartis AG to develop treatments for hearing loss and balance disorders worldwide. GenVec is also working with companies and organizations such as Merial, and the U.S. Government on vaccine development. The U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) gave conditional approval to GenVec's foot-and-mouth disease (FMD) vaccine in the middle of 2012. This was a significant achievement as it marked GenVec's first approved product.In June 2001, GenVec announced the issuance of a U.S. patent covering formulation methods for preserving adenovectors.In Aug 2006, GenVec entered the first human therapeutic clinical trial involving the company's adenoviral-vector technology used in an HIV vaccine candidate at Vaccine Research Center at NIH.".
- GenVec industry Pharmaceutical_industry.
- GenVec location Gaithersburg,_Maryland.
- GenVec location United_States.
- GenVec netIncome "1.84E7".
- GenVec numberOfEmployees "85".
- GenVec product Clinical_trial.
- GenVec product GenVec.
- GenVec revenue "1.39E7".
- GenVec type Public_company.
- GenVec wikiPageExternalLink www.genvec.com.
- GenVec wikiPageID "16748286".
- GenVec wikiPageRevisionID "572135871".
- GenVec companyLogo "220".
- GenVec companyName "GenVec, Inc.".
- GenVec companyType Public_company.
- GenVec hasPhotoCollection GenVec.
- GenVec homepage www.genvec.com.
- GenVec industry Pharmaceutical_industry.
- GenVec keyPeople "Cynthia Collins, President and CEO".
- GenVec keyPeople "Douglas J. Swirsky, Senior Vice President and Chief Financial Officer".
- GenVec location Gaithersburg,_Maryland.
- GenVec location United_States.
- GenVec netIncome "1.84E7".
- GenVec numEmployees "85".
- GenVec products "TNFeradeTM Phase III".
- GenVec revenue "1.39E7".
- GenVec wordnet_type synset-company-noun-1.
- GenVec subject Category:Biotechnology_companies_of_the_United_States.
- GenVec subject Category:Companies_based_in_Gaithersburg,_Maryland.
- GenVec subject Category:Companies_listed_on_NASDAQ.
- GenVec subject Category:Pharmaceutical_companies_of_the_United_States.
- GenVec type Abstraction100002137.
- GenVec type BiotechnologyCompanies.
- GenVec type CompaniesBasedInMontgomeryCounty,Maryland.
- GenVec type CompaniesListedOnNASDAQ.
- GenVec type Company108058098.
- GenVec type DrugCompany108002578.
- GenVec type Group100031264.
- GenVec type Institution108053576.
- GenVec type Organization108008335.
- GenVec type PharmaceuticalCompaniesOfTheUnitedStates.
- GenVec type SocialGroup107950920.
- GenVec type YagoLegalActor.
- GenVec type YagoLegalActorGeo.
- GenVec type YagoPermanentlyLocatedEntity.
- GenVec type Agent.
- GenVec type Company.
- GenVec type Organisation.
- GenVec type Organization.
- GenVec type Agent.
- GenVec type SocialPerson.
- GenVec type Thing.
- GenVec comment "GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. GenVec currently has a collaboration with Novartis AG to develop treatments for hearing loss and balance disorders worldwide. GenVec is also working with companies and organizations such as Merial, and the U.S. Government on vaccine development. The U.S.".
- GenVec label "GenVec".
- GenVec sameAs m.03p270n.
- GenVec sameAs Q5530847.
- GenVec sameAs Q5530847.
- GenVec sameAs GenVec.
- GenVec wasDerivedFrom GenVec?oldid=572135871.
- GenVec homepage www.genvec.com.
- GenVec isPrimaryTopicOf GenVec.
- GenVec name "GenVec, Inc.".